Corporate Banner
Satellite Banner
Technology Networks Header
Monday, December 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Consistent & Efficient Purification of NGS Library Reactions
Tuesday, June 24, 2014
MagSi-NGSPREP offers an efficient solution for DNA clean-up and size selection.

Bioo Scientific Releases Sciclone and Biomek Protocols
Saturday, June 21, 2014
Protocols designed to eliminate NGS library prep bottlenecks.

DNASTAR Releases Lasergene 12 Software
Thursday, June 19, 2014
Lasergene 12 improves sequence alignments and NGS accuracy.

New Molecular Biology Tools Drive Efficiency across a Range of Applications
Wednesday, June 11, 2014
New convenience features and rapid protocols leave more time for analysis and discovery.

Agilent Introduces SureSelectQXT Target Enrichment Kits
Wednesday, June 04, 2014
Solution empowers clinical research sequencing with quick workflow, minimal sample input.

OGT to Sell Cytocell Products Direct in North America
Monday, June 02, 2014
The acquisition brings immediate customer benefits.

Contract Research Organizations Adopt Ion Torrent Next-Generation Sequencing Platform
Monday, June 02, 2014
MolecularMD and Selah Genomics to Use Oncomine Cancer Research Panel for Clinical Trial Design.

Advanced Liquid Level Detection with Tecan’s Cavro® Omni Robot
Thursday, May 22, 2014
Offers ‘hybrid’ liquid sensing, provides exceptional process security and full traceability.

New 20µl Liquidator 96 from Anachem
Thursday, May 22, 2014
Maximizes users workflow with fast, 96-well pipetting and no complex programming.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 223
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn